TY - JOUR
T1 - Utility of the Ages and Stages Questionnaire to Identify Developmental Delay in Children Aged 12 to 60 Months A Systematic Review and Meta-analysis
AU - Muthusamy, Saravanan
AU - Wagh, Deepika
AU - Tan, Jason
AU - Bulsara, Max
AU - Rao, Shripada
PY - 2022/10
Y1 - 2022/10
N2 - IMPORTANCE The Ages and Stages Questionnaire (ASQ) is a commonly used developmental screening tool, but its utility is debated. OBJECTIVES To conduct a a systematic review and meta-analysis to evaluate ASQ's utility as a screening or diagnostic tool to identify developmental delay in children aged 12-60 months. DATA SOURCES Medline, EMBASE, CINAHL, PsycINFO, and Mednar were searched from inception until December 2021.STUDY SELECTION Studies meeting both criteria were included. ASQ was performed at age 12 to 60 months or where the median age at ASQ was at least 12 months and formal developmental assessments were done within 2 months of ASQ.DATA EXTRACTION AND SYNTHESIS True positive, false positive, false negative, and true negatives from individual studies were extracted. Meta-analysis was conducted with Stata version 16.1. Risk of bias was assessed using the QUADAS-2 tool. Certainty of evidence (COE) was assessed using GRADE guidelines. MAIN OUTCOMES AND MEASURES Ability of ASQ scores more than 2 SDs below the mean in more than 1 domain (ASQ-25D) to identify any developmental delay or severe delay. Based on generally accepted interpretation of likelihood ratio (LR) values, a positive LR (PLR) more than 5 and a negative LR (NLR) of 0.2 or less were considered necessary to rule in or rule out developmental delay, respectively, with at least moderate probability. RESULTS Initial search yielded 5777 citations of which 43 were included in the review. Of them, 36 were included in the meta-analysis. The pooled sensitivity, specificity, PLR. and NLR are as follows: ASQ-25D to predict any delay in 1 or more domain (n = 16), 0.77 (95% CI, 0.64-0.86), 0.81(95% CI, 0.75-0.86). 4.10 (95% CI, 3.17-5.30), and 0.28 (95% CI, 0.18-0.44); ASQ-250 to predict severe delay in 1 or more domain (n = 15), 0.84 (95% CI, 0.75-0.90), 0.77 (95% CI, 0.71-0.82), 3.72 (95% CI, 2.98-4.64), and 0.20 (95% CI, 0.13-0.32); ASQ-2SD motor domain to predict motor delay (n = 7), 0.41(95% CI, 0.26-0.57), 0.94 (95% CI, 0.87-0.97), 6.5 (95% CI, 3.8-11.1), and 0.63 (95% CI, 0.50-0.81); and ASQ-2SD cognitive domain to predict cognitive delay (n = 2), 0.44 (95% CI, 0.24-0.65), 0.93 (95% CI, 0.81-0.95), 6.4 (95% CI, 2.4-16.8), and 0.61(95% CI, 0.43-0.86). The COE was low/very low. CONCLUSIONS AND RELEVANCE If a child aged 12 to 60 months passes all ASQ domains, there is a moderate probability that they do not have severe developmental delay (low COE). If a child aged 12-60 months fails the motor or cognitive domain of ASQ, there is a moderate probability that they have some motor or cognitive delay, respectively (very low COE).
AB - IMPORTANCE The Ages and Stages Questionnaire (ASQ) is a commonly used developmental screening tool, but its utility is debated. OBJECTIVES To conduct a a systematic review and meta-analysis to evaluate ASQ's utility as a screening or diagnostic tool to identify developmental delay in children aged 12-60 months. DATA SOURCES Medline, EMBASE, CINAHL, PsycINFO, and Mednar were searched from inception until December 2021.STUDY SELECTION Studies meeting both criteria were included. ASQ was performed at age 12 to 60 months or where the median age at ASQ was at least 12 months and formal developmental assessments were done within 2 months of ASQ.DATA EXTRACTION AND SYNTHESIS True positive, false positive, false negative, and true negatives from individual studies were extracted. Meta-analysis was conducted with Stata version 16.1. Risk of bias was assessed using the QUADAS-2 tool. Certainty of evidence (COE) was assessed using GRADE guidelines. MAIN OUTCOMES AND MEASURES Ability of ASQ scores more than 2 SDs below the mean in more than 1 domain (ASQ-25D) to identify any developmental delay or severe delay. Based on generally accepted interpretation of likelihood ratio (LR) values, a positive LR (PLR) more than 5 and a negative LR (NLR) of 0.2 or less were considered necessary to rule in or rule out developmental delay, respectively, with at least moderate probability. RESULTS Initial search yielded 5777 citations of which 43 were included in the review. Of them, 36 were included in the meta-analysis. The pooled sensitivity, specificity, PLR. and NLR are as follows: ASQ-25D to predict any delay in 1 or more domain (n = 16), 0.77 (95% CI, 0.64-0.86), 0.81(95% CI, 0.75-0.86). 4.10 (95% CI, 3.17-5.30), and 0.28 (95% CI, 0.18-0.44); ASQ-250 to predict severe delay in 1 or more domain (n = 15), 0.84 (95% CI, 0.75-0.90), 0.77 (95% CI, 0.71-0.82), 3.72 (95% CI, 2.98-4.64), and 0.20 (95% CI, 0.13-0.32); ASQ-2SD motor domain to predict motor delay (n = 7), 0.41(95% CI, 0.26-0.57), 0.94 (95% CI, 0.87-0.97), 6.5 (95% CI, 3.8-11.1), and 0.63 (95% CI, 0.50-0.81); and ASQ-2SD cognitive domain to predict cognitive delay (n = 2), 0.44 (95% CI, 0.24-0.65), 0.93 (95% CI, 0.81-0.95), 6.4 (95% CI, 2.4-16.8), and 0.61(95% CI, 0.43-0.86). The COE was low/very low. CONCLUSIONS AND RELEVANCE If a child aged 12 to 60 months passes all ASQ domains, there is a moderate probability that they do not have severe developmental delay (low COE). If a child aged 12-60 months fails the motor or cognitive domain of ASQ, there is a moderate probability that they have some motor or cognitive delay, respectively (very low COE).
KW - DIAGNOSTIC-TEST ACCURACY
KW - INFANT DEVELOPMENT-II
KW - PARENT-COMPLETED AGES
KW - SCREENING-TEST
KW - CONCURRENT VALIDITY
KW - BAYLEY SCALES
KW - FOLLOW-UP
KW - PUBLICATION BIAS
KW - 3RD EDITION
KW - TESTS
UR - http://www.scopus.com/inward/record.url?scp=85137289921&partnerID=8YFLogxK
U2 - 10.1001/jamapediatrics.2022.3079
DO - 10.1001/jamapediatrics.2022.3079
M3 - Review article
C2 - 36036913
SN - 2168-6203
VL - 176
SP - 980
EP - 989
JO - JAMA Pediatrics
JF - JAMA Pediatrics
IS - 10
ER -